Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Extends Invader Contract With Japanese Reference Lab BML

NEW YORK, Jan. 8 (GenomeWeb News) - Third Wave Technologies has extended its multi-year partnership with BML, a Tokyo-based clinical reference lab, by at least one year, Third Wave said today.

The companies will continue their collaboration, begun in December 2000, to use Third Wave's Invader technology to develop and commercialize molecular diagnostic tests for infectious diseases.

The original agreement the agreement called for BML to pay Third Wave $3 million up front, and provide $4 million in funding for Invader product development over the next three years. In exchange, Third Wave retained the right to market and sell any products developed under the agreement outside Japan, and will later acquire rights to develop and market these products inside Japan.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.